u 69593 has been researched along with n-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)phenylacetamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, RD; Nelson, WL; Weerawarna, SA | 1 |
| Ferguson, DM; Larson, DL; Paterlini, MG; Portoghese, PS; Subramanian, G | 1 |
2 other study(ies) available for u 69593 and n-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)phenylacetamide
| Article | Year |
|---|---|
Isothiocyanate-substituted kappa-selective opioid receptor ligands derived from N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl] phenylacetamide.
Topics: Acetamides; Acetanilides; Animals; Binding, Competitive; Brain; Guinea Pigs; In Vitro Techniques; Isothiocyanates; Radioligand Assay; Receptors, Opioid, kappa; Stereoisomerism | 1994 |
Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists.
Topics: Acetamides; Binding Sites; Ligands; Models, Molecular; Molecular Conformation; Mutagenesis, Site-Directed; Receptors, Opioid, kappa; Structure-Activity Relationship | 1998 |